Nicolas Mavroudakis

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 169 citations · Full text

Late-onset Pompe Disease, Autoimmune Disease, Clinical Infectious Disease +3

Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera

Émilien Delmont, Alexandre Brodovitch, Ludivine Kouton et al. · Journal of Neurology · 2020 · 103 citations · Full text

Rheumatology, Medical Diagnostics, Allergy +10

Effects of diphenylhydantoin on motor potentials evoked with magnetic stimulation

Nicolas Mavroudakis, Jean Marc Caroyer, Eric Brunko et al. · Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section · 1994 · 96 citations

Stimulation Device, Neurophysiology, Medicine +12

Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy

Moglie Le Quintrec, Maxime Teisseyre, Nicole Bec et al. · Kidney International · 2021 · 91 citations · Full text

Glomerular Disease, Inflammation, Autoimmune Disease +12

Abnormal motor evoked responses to transcranial magnetic stimulation in focal dystonia

Nicolas Mavroudakis, Jean Marc Caroyer, Eric Brunko et al. · Neurology · 1995 · 74 citations